Protein Stability in Polymer Delivery Systems
聚合物输送系统中的蛋白质稳定性
基本信息
- 批准号:6629146
- 负责人:
- 金额:$ 19.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-15 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Verbatim from the Applicant's Abstract): Protein drugs are
currently administered systemically by injections. For individuals requiring
chronic therapy, self-administration with a needle is an unpleasant everyday
experience. However, development of injectable biodegradable polymers (e.g.,
poly(lactide-co-glycolides), PLGA) capable of slowly and continuously releasing
proteins for months between injections may provide a realistic alternative to
painful daily injections. PLGA delivery systems are also used for local therapy
and for delivery of vaccines. The primary obstacle to develop PLGA delivery
systems for proteins is the irreversible instability of these agents prior to
their release in vivo. The overall goal of these studies is to determine the
underlying molecular mechanisms responsible for the instability of proteins in
PLGA and to use this information to develop widely applicable stabilization
approaches. In this proposal, the pH in the polymer will be manipulated with
antacid excipients to improve the stability of model proteins encapsulated in
PLGA. This general stabilization approach will then be tested with therapeutic
proteins that promote angiogenesis. Slow-release angiogenic agents have
important applications for patients with ischemic heart disease (responsible
for about 5OO,OOO deaths annually in the U. S.). The ensuing site-specific
neovascularization would facilitate myocardial perfusion and reduce cardiac
complications such as myocardial infarction, angina pectoris, heart failure,
and/or sudden cardiac death. Slow-release growth factors may also be useful to
improve survival of tissues after implantation of tissue engineering scaffolds.
Considering the potential impact of PLGA delivery systems that slowly release
native therapeutic proteins, such as those that promote angiogenesis, could
have on human health, the importance in resolving the poor instability of
proteins encapsulated in PLGAs becomes unmistakable. This proposal will test
the following hypothesis: Moisture and acidic pH inside PLGAs during protein
release are the two most common stresses responsible for instability of
proteins in PLGA delivery systems, including microspheres. Development of
methods to regulate pH in the polymer as well as aqueous protein solubility
will become widely applicable techniques to stabilize encapsulated proteins.
This hypothesis will be tested in the following specific aims: (1)
Characterization of physical chemical processes in the polymer microclimate
that influence stability and release of encapsulated proteins; (2)
Investigation of stability of model proteins in PLGA delivery systems; (3)
Application of the stabilization methodology to the delivery of therapeutic
angiogenic proteins; and (4) In vivo assessment of the controlled release of
biologically active angiogenic proteins.
描述(逐字摘自申请人摘要):蛋白质药物是
目前通过注射进行全身给药。对于需要的个人
慢性治疗,用针自我给药是每天不愉快的事情
经验。然而,可注射生物降解聚合物的开发(例如,
聚(丙交酯-乙交酯),PLGA)能够缓慢且连续地释放
两次注射之间持续数月的蛋白质可能提供一种现实的替代方案
每天注射都很痛苦。 PLGA 递送系统也用于局部治疗
以及疫苗的运送。开发PLGA递送的主要障碍
蛋白质系统的关键在于这些试剂在形成之前具有不可逆的不稳定性
它们在体内的释放。这些研究的总体目标是确定
导致蛋白质不稳定的潜在分子机制
PLGA 并利用这些信息来开发广泛适用的稳定性
接近。在该提案中,聚合物中的 pH 值将通过以下方式控制:
抗酸剂赋形剂可提高封装模型蛋白的稳定性
PLGA。然后将用治疗方法来测试这种一般的稳定方法
促进血管生成的蛋白质。缓释血管生成剂具有
对于缺血性心脏病患者的重要应用(负责
美国每年约有 500,000 人死亡)。接下来的具体地点
新生血管形成有利于心肌灌注并减少心脏
心肌梗塞、心绞痛、心力衰竭等并发症,
和/或心源性猝死。缓释生长因子也可能有助于
提高组织工程支架植入后组织的存活率。
考虑缓慢释放的 PLGA 输送系统的潜在影响
天然治疗蛋白,例如促进血管生成的蛋白,可以
对人类健康而言,解决贫困不稳定问题具有重要意义
封装在 PLGA 中的蛋白质变得明确无误。该提案将测试
以下假设:蛋白质加工过程中 PLGA 内的水分和酸性 pH 值
释放是造成不稳定的两个最常见的压力
PLGA 递送系统中的蛋白质,包括微球。发展
调节聚合物 pH 值以及蛋白质水溶性的方法
将成为广泛应用的稳定封装蛋白质的技术。
该假设将在以下具体目标中得到检验:(1)
聚合物微气候中物理化学过程的表征
影响封装蛋白的稳定性和释放; (2)
PLGA 递送系统中模型蛋白的稳定性研究; (3)
稳定方法在治疗药物递送中的应用
血管生成蛋白; (4) 体内控释评估
具有生物活性的血管生成蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN P. SCHWENDEMAN其他文献
STEVEN P. SCHWENDEMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN P. SCHWENDEMAN', 18)}}的其他基金
Controlled Photochemical Release of Nitric Oxide for Biomedical Applications
用于生物医学应用的一氧化氮的受控光化学释放
- 批准号:
10186743 - 财政年份:2020
- 资助金额:
$ 19.47万 - 项目类别:
Controlled Photochemical Release of Nitric Oxide for Biomedical Applications
用于生物医学应用的一氧化氮的受控光化学释放
- 批准号:
10377507 - 财政年份:2020
- 资助金额:
$ 19.47万 - 项目类别:
Controlled Photochemical Release of Nitric Oxide for Biomedical Applications
用于生物医学应用的一氧化氮的受控光化学释放
- 批准号:
10590662 - 财政年份:2020
- 资助金额:
$ 19.47万 - 项目类别:
Controlled Photo-Release of Nitric Oxide for Antimicrobial Inhalation Therapy
用于抗菌吸入疗法的一氧化氮的受控光释放
- 批准号:
9298198 - 财政年份:2017
- 资助金额:
$ 19.47万 - 项目类别:
Investigation of peptide-polymer interactions in PLGA microspheres
PLGA 微球中肽-聚合物相互作用的研究
- 批准号:
9346576 - 财政年份:2016
- 资助金额:
$ 19.47万 - 项目类别:
In vitro-In vivo correlations of parenteral microsphere drug products
肠外微球药物产品的体外-体内相关性
- 批准号:
9131455 - 财政年份:2013
- 资助金额:
$ 19.47万 - 项目类别:
In vitro-In vivo correlations of parenteral microsphere drug products
肠外微球药物产品的体外-体内相关性
- 批准号:
8670377 - 财政年份:2013
- 资助金额:
$ 19.47万 - 项目类别:
Protein Stability in Polymer Delivery Systems
聚合物输送系统中的蛋白质稳定性
- 批准号:
7844194 - 财政年份:2009
- 资助金额:
$ 19.47万 - 项目类别:
Self-microencapsulation in polymer delivery systems without organic solvents
不含有机溶剂的聚合物输送系统中的自微囊化
- 批准号:
7739678 - 财政年份:2009
- 资助金额:
$ 19.47万 - 项目类别:
Self-microencapsulation in polymer delivery systems without organic solvents
不含有机溶剂的聚合物输送系统中的自微囊化
- 批准号:
7894812 - 财政年份:2009
- 资助金额:
$ 19.47万 - 项目类别:
相似国自然基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
- 批准号:81200692
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Igniting Life with Sparks of Light: 3D Spatiotemporal Photoactivation of Angiogenesis via Radiational Kinesis (3D SPARK)
用光的火花点燃生命:通过辐射运动进行血管生成的 3D 时空光激活 (3D SPARK)
- 批准号:
MR/X034976/1 - 财政年份:2024
- 资助金额:
$ 19.47万 - 项目类别:
Fellowship
The impact of Hyaluronic Acid on growth factor signalling and angiogenesis
透明质酸对生长因子信号传导和血管生成的影响
- 批准号:
DP240101674 - 财政年份:2024
- 资助金额:
$ 19.47万 - 项目类别:
Discovery Projects
Temporospatial Single-Cell Characterization of Angiogenesis and Myocardial Regeneration in Small and Large Mammals
小型和大型哺乳动物血管生成和心肌再生的时空单细胞表征
- 批准号:
10751870 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Interrogating the Potential of Ccn1+ Astrocyte Niches to Drive Angiogenesis after Spinal Cord Injury
探讨 Ccn1 星形胶质细胞生态位在脊髓损伤后驱动血管生成的潜力
- 批准号:
10607960 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Endothelial von Willebrand factor and the tissue-specific regulation of angiogenesis and vascular integrity
内皮血管性血友病因子和血管生成和血管完整性的组织特异性调节
- 批准号:
MR/X021106/1 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Research Grant
Angiogenesis process in wound healing and vascular grafting and the role of pericytes.
血管生成过程在伤口愈合和血管移植中以及周细胞的作用。
- 批准号:
23K15172 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Astrocyte-specific molecular cues guiding retinal angiogenesis
星形胶质细胞特异性分子线索指导视网膜血管生成
- 批准号:
10676468 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Molecular mechanisms underlying heme transport at the blood-brain barrier and its role in angiogenesis
血红素在血脑屏障转运的分子机制及其在血管生成中的作用
- 批准号:
10572752 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Network models of differentiation landscapes for angiogenesis and hematopoiesis
血管生成和造血分化景观的网络模型
- 批准号:
10622797 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Sexual dimorphism in right (-sided) heart failure: Role of sphingosine kinsae-1 and progesterone in right ventricular angiogenesis and remodelling
右(侧)心力衰竭的性别二态性:鞘氨醇 kinsae-1 和黄体酮在右心室血管生成和重塑中的作用
- 批准号:
479618 - 财政年份:2023
- 资助金额:
$ 19.47万 - 项目类别:
Operating Grants